We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCFC
2726
DELISTED
The Community Financial Corporation Common Stock
TCFC
$8K ﹤0.01%
243
-229
-49% -$7.01K
NIQ
2727
DELISTED
NUVEEN INTERMEDIATE DURATION QUALITY MUNICIPAL TERM FUND
NIQ
$8K ﹤0.01%
+608
New +$7.98K
SECO
2728
DELISTED
Secoo Holding Limited ADR
SECO
$8K ﹤0.01%
+104
New +$8.95K
ICBK
2729
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$8K ﹤0.01%
442
+426
+2,663% +$7.47K
NMY
2730
DELISTED
Nuveen Maryland Quality Municipal Income Fund
NMY
$8K ﹤0.01%
+641
New +$8.14K
NUM
2731
DELISTED
Nuveen Michigan Quality Municipal Income Fund
NUM
$8K ﹤0.01%
+596
New +$7.97K
PRVL
2732
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$8K ﹤0.01%
+614
New +$8.95K
YGYI
2733
DELISTED
Youngevity International, Inc Common Stock
YGYI
$8K ﹤0.01%
1,287
+586
+84% +$3.38K
PFNX
2734
DELISTED
Pfenex Inc.
PFNX
$8K ﹤0.01%
1,185
-442
-27% -$2.83K
PACQU
2735
DELISTED
Pure Acquisition Corp. Unit
PACQU
$8K ﹤0.01%
758
LTS
2736
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$8K ﹤0.01%
2,305
+2,105
+1,053% +$7.28K
ADRD
2737
DELISTED
Invesco BLDRS Developed Markets 100 ADR Index Fund
ADRD
$8K ﹤0.01%
360
SNNA
2738
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$8K ﹤0.01%
9,107
+6,757
+288% +$10.6K
SSFN
2739
DELISTED
Stewardship Financial Corp
SSFN
$8K ﹤0.01%
536
-868
-62% -$9.53K
BKS
2740
DELISTED
Barnes & Noble
BKS
$8K ﹤0.01%
1,270
-1,650
-57% -$9K
DHXM
2741
DELISTED
DHX Media Ltd. Common Voting and Variable Voting Shares
DHXM
$8K ﹤0.01%
5,600
-100
-2% -$142
TEUM
2742
DELISTED
Pareteum Corporation
TEUM
$8K ﹤0.01%
+2,900
New +$11.5K
BDSI
2743
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$8K ﹤0.01%
1,700
-10,206
-86% -$47.5K
ACRE
2744
Ares Commercial Real Estate
ACRE
$270M
$7K ﹤0.01%
+467
New +$7.05K
AMC icon
2745
AMC Entertainment Holdings
AMC
$2.31B
$7K ﹤0.01%
70
-30
-30% -$4K
ARCB icon
2746
ArcBest
ARCB
$3.08B
$7K ﹤0.01%
254
-449
-64% -$13.1K
AUPH icon
2747
Aurinia Pharmaceuticals
AUPH
$2.11B
$7K ﹤0.01%
1,148
-152
-12% -$969
BEEM icon
2748
Beam Global
BEEM
$25.3M
$7K ﹤0.01%
+1,466
New +$7.76K
BMA icon
2749
Banco Macro
BMA
$5.35B
$7K ﹤0.01%
100
-455
-82% -$23.5K
BME icon
2750
BlackRock Health Sciences Trust
BME
$570M
$7K ﹤0.01%
+182
New +$6.92K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.